Liver Transplantation Market: By Treatment (Liver Transplantation Surgery, Post-Surgery Anti-Rejection Treatment), By End-User (Hospitals, Adult Liver Transplantation Centers, Ambulatory Surgical Centers) & By Region-Forecast (2016-2021)
[Report Updated: 25-02-2016]


Related Topics: Liver Transplantation , Transplantation

Sorry, this report is no longer available.

We may have other suitable reports available - try Searching for Liver
or contact our sales team for personal assistance: phone +44 (0)7887945155 or email pdb@bioportfolio.co.uk.

Introduction

Liver transplantation or hepatic transplantation is a medical surgical procedure performed on a patient suffering from the liver failure and is unable to to perform its normal functions such as synthesis of carbohydrates, proteins and fats. Liver failure is majorly caused by several disease conditions like liver cirrhosis, cystic fibrosis, hemochromatosis, primary biliary cirrhosis, primary sclerosing cholangitis and wilson’s disease. Liver transplantation is second most commonly transplantation surgery performed after the kidney, making it clear that liver disease is a common and serious problem. Majority of liver transplant operations use livers from deceased donors, though a liver may also come from another living person (allograft). Globally increasing awareness and spending on healthcare is expected to drive the demand for liver transplantation during the period of study.

Liver Transplantation Market

Geographically North America dominated global liver transplantation market driven by best in the class healthcare infrastructure, advanced facilities and awareness and higher spending by the citizens towards healthcare expenditure. North America was followed by Europe and Asia-Pacific as second and third largest market for liver transplantation surgery market. Asia Pacific is projected to have fastest growth, owing to rapidly increasing healthcare infrastructure, increased spending, government initiatives and increasing awareness amongst population, and growing medical tourism industry in developing nations such as China, and India in this region.

This report identifies the global liver transplantation market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global liver transplantation market.

This report segments global liver transplantation market on the basis of treatment, end-user and regional market as follows:

Liver Transplantation Market, By Treatment: Liver Transplantation Surgery, Post-Surgery Anti-Rejection Treatment(Cyclosporine, Tacrolimus, Sirolimus, Prednisone, Azathioprine, Mycophenolate Mofetil)

Liver Transplantation Market, By End-Usert: Hospitals, Adult Liver Transplantation Centers, Ambulatory Surgical Centers

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the liver transplantation market. Some of the major companies’ profiles in detail are as follows:

Conatus Pharmaceuticals Inc.

Digna Biotech.

Dompe Farmaceutici S.p.A.

Isogenis, Inc.

RedHill Biopharma Ltd.

Table of Contents
for Liver Transplantation Market: By Treatment (Liver Transplantation Surgery, Post-Surgery Anti-Rejection Treatment), By End-User (Hospitals, Adult Liver Transplantation Centers, Ambulatory Surgical Centers) & By Region-Forecast (2016-2021) [Report Updated: 25-02-2016]

  • 1. Liver Transplantation Market – Market Overview

    2. Executive Summary

    3. Market Landscape

    3.1. Market Share Analysis

    3.2. Comparative Analysis

    3.3. Product Benchmarking

    3.4. End User Profiling

    3.5. Top 5 Financials Analysis

    4. Liver Transplantation Market– Market Forces

    4.1. Drivers

    4.1.1. Growing prevalence of Hepatitis A, B and C

    4.2. Restraints

    4.2.1. Inadequate number of donors

    4.3. Opportunities

    4.3.1. Emerging economies

    4.4. Challenges

    4.5. Porter’s Five Forces Analysis

    4.5.1. Bargaining Power of Suppliers

    4.5.2. Bargaining Power of Buyers

    4.5.3. Threat of New Entrants

    4.5.4. Threat of Substitutes

    4.5.5. Degree of Competition

    5. Liver Transplantation Market– Strategic Analysis

    5.1. Value Chain Analysis

    5.2. Pricing Analysis

    5.3. Opportunities Analysis

    5.4. Product/Market Life Cycle Analysis

    5.5. Suppliers and Distributors

    6. Liver Transplantation Market, By Treatment

    6.1. Liver Transplantation Surgery

    6.2. Surgery Anti-Rejection Treatment

    6.2.1. Cyclosporine

    6.2.2. Tacrolimus

    6.2.3. Sirolimus

    6.2.4. Prednisone

    6.2.5. Azathioprine

    6.2.6. Mycophenolate Mofetil

    7. Liver Transplantation Market, By End-User

    7.1. Hospitals

    7.2. Adult Liver Transplantation Centers

    7.3. Ambulatory Surgical Centers

    8. Liver Transplantation Market, By Geography

    8.1. Europe

    8.1.1. Germany

    8.1.2. France

    8.1.3. Italy

    8.1.4. Spain

    8.1.5. Russia

    8.1.6. U.K.

    8.1.7. Rest of Europe

    8.2. Asia Pacific

    8.2.1. China

    8.2.2. India

    8.2.3. Japan

    8.2.4. South Korea

    8.2.5. Rest of Asia-Pacific

    8.3. North America

    8.3.1. U.S.

    8.3.2. Canada

    8.3.3. Mexico

    8.4. Rest of the World (RoW)

    8.4.1. Brazil

    8.4.2. Rest of RoW

    9. Liver Transplantation – Market Entropy

    9.1. Expansion

    9.2. Technological Developments

    9.3. Merger & Acquisitions, and Joint Ventures

    9.4. Supply- Contract

    10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

    10.1. Allosource

    10.2. Conatus Pharmaceuticals Inc.

    10.3. Digna Biotech

    10.4. S.L.

    10.5. Dompe Farmaceutici S.p.A.

    10.6. Isogenis, Inc.

    10.7. RedHill Biopharma Ltd.

    10.8. Thompson Surgical

    10.9. Integra Life sciences

    10.10. Dompe Farmaceutici S.p.A

    *More than 40 Companies are profiled in this Research Report, Complete List available on Request*

    "*Financials would be provided on a best efforts basis for private companies"

    11. Appendix

    11.1. Abbreviations

    11.2. Sources

    11.3. Research Methodology

    11.4. Bibliography

    11.5. Compilation of Expert Insights

    11.6. Disclaimer

List Of Tables
in Liver Transplantation Market: By Treatment (Liver Transplantation Surgery, Post-Surgery Anti-Rejection Treatment), By End-User (Hospitals, Adult Liver Transplantation Centers, Ambulatory Surgical Centers) & By Region-Forecast (2016-2021) [Report Updated: 25-02-2016]

No

Additional Details

Publisher

Publisher Information

Reference

80414 | HCR 0315

Report Format

PDF

 Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Liver Cancer Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Global Liver Disease Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016
Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016SummaryGlobalData's Medical...
14 Sep 2016 by Global Data USD $4,000 More Info
One Way Liver, S.L. - Medical Equipment - Deals and Alliances Profile
SummaryONE WAY LIVER, S.L (OWL), formerly One Way Liver Genomics, S.L., is a biotechnology company t...
22 Aug 2016 by Global Data USD $250 More Info
One Way Liver, S.L. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryONE WAY LIVER, S.L (OWL), formerly One Way Liver Genomics, S.L., is a biotechnology company t...
10 May 2016 by Global Data USD $250 More Info
One Way Liver, S.L. - Medical Equipment - Deals and Alliances Profile
SummaryONE WAY LIVER, S.L (OWL), formerly One Way Liver Genomics, S.L., is a biotechnology company t...
15 Apr 2016 by Global Data USD $250 More Info
One Way Liver, S.L. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryONE WAY LIVER, S.L (OWL), formerly One Way Liver Genomics, S.L., is a biotechnology company t...
15 Mar 2016 by Global Data USD $250 More Info
One Way Liver, S.L. - Medical Equipment - Deals and Alliances Profile
SummaryONE WAY LIVER, S.L (OWL), formerly One Way Liver Genomics, S.L., is a biotechnology company t...
25 Feb 2016 by Global Data USD $250 More Info
Liver Diseases Global Clinical Trials Review, H2, 2015
Liver Diseases Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial report, “Li...
16 Dec 2015 by Global Data USD $2,500 More Info
Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H2, 2015
Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H2, 2015SummaryGlobalData's...
16 Dec 2015 by Global Data USD $2,500 More Info

We Stock...